Artikel
Tumor containment by immune cells and fibrotic capsule improve survival of patients following resection of colorectal liver metastasis
Suche in Medline nach
Autoren
Veröffentlicht: | 21. März 2014 |
---|
Gliederung
Text
Introduction: Liver metastases occur in 40-50% of patients with colorectal cancer and determine longterm survival. The aim of this study was to examine the immunologic architecture of colorectal liver metastasis and its impact on patient survival.
Material and methods: 222 colorectal liver metastases were stained for H&E, masson trichrome, alpha smooth muscle actin, CD4, CD45RO and CD8. Besides histomorphologic evaluation, the immunohistochemical stainings were analysed for CD4+, CD45RO+ and CD8+ cell numbers separately for tumor, infiltrative margin and distant liver stroma. These findings were correlated with clinical data and patient outcome.
Results: Tumor containment by fibrotic capsule formation around the liver metastasis, observed in 38% of the patients, was a prognostic parameter for patient survival (P<0.0001) and independently lead to higher R0-resection rates (P=0.03). Dense infiltration of CD4+, CD45RO+ and CD8+ cells at the infiltrative margin correlated with increased patient survival (P=0.0002; P<0.0001; P=0.0098). In particular, localized cell infiltration at the infiltrative margin with low cell infiltration in the distant liver stroma, expressed by a ratio of CD4+, CD45RO+ and CD8+ cells >2, prolonged patient survival time (P<0.0001; P=0.0002; P<0.0001). Using these factors, a cellular immune score was designed that stratifies patient survival (P<0.0001).
Conclusion: Fibrotic capsule formation and localized cell infiltration of colorectal liver metastasis by CD4+, CD45RO+ and CD8+ cells prolong patient survival. Based on these immunologic criteria we developed a cellular immune score to stratify patients according to prognosis which potentially extends the immune scoring classification planned for primary colorectal carcinomas to patients with colorectal liver metastasis.